FDA Law Blog discusses ADAPT Act Would Create a New Limited Population Approval Pathway for Antibiotics and Antifungals

December 13, 2013

By Kurt R. Karst –    

On December 12th, a group of bipartisan lawmakers led by Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) introduced H.R. 3742, the Antibiotic Development to Advance Patient Treatment Act of 2013 (“ADAPT Act”).  If enacted, the ADAPT Act would, among other things, amend the law to create a pathway for the prompt approval of antibacterial and antifungal drugs intended to treat serious or life-threatening diseases or conditions. 

continue to read here